CS logo
small CS logo
The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis

Ottawa, Ontario, Canada

About The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis


During the past decade, The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis


According to Clinical.Site data, the most researched conditions in "The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis" are "Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis" in a lesser frequency.

Clinical Trials Intervention Types at The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis


Most popular intervention types in "The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (3 trials), "Fenebrutinib" (2 trials), "Placebo" (1 trials), "Placebo matched to fenebrutinib" (1 trials) and "Placebo matched to ocrelizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis


The vast majority of trials in "The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis" are 4 trials for "All" genders.

Clinical Trials Status at The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis


Currently, there are NaN active trials in "The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Ottawa Hospital - General Campus; Department of Neurology - Multiple Sclerosis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".